We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Heptares

News List

Sosei Heptares, Takeda Enter R&D Partnership contractpharma
August 06, 2019
Could be worth more than $1.2 billion and involves small molecules and biologics.
Heptares doses first subject in Alzheimer’s drug trial pharmatimes
September 04, 2017
London, UK-based Heptares Therapeutics says the first healthy subject has now been dosed with its first-in-class, selective muscarinic M4 receptor agonist HTL0016878 in a Phase I clinical study.
Heptares’ Fiona Marshall receives 2017 John Daly Lecture Award pharmaasia
June 01, 2017
Co-Founder and Chief Scientific Officer of Heptares receives award in recognition of her outstanding contribution to GPCR Drug Discovery.